Cancer Drugs in Europe- A Comparison of HTA Processes and Decisions for New and Innovative Oncology Therapies in France, Germany and The UK – An Analysis Using The Prismaccess Database
Abstract
Authors
D Droeschel M Hartmann L Vollmer S Walzer B de Paz